Cantú syndrome: Findings from 74 patients in the International Cantú Syndrome Registry
Cantú syndrome (CS), first described in 1982, is caused by pathogenic variants in ABCC9 and KCNJ8, which encode the regulatory and pore forming subunits of ATP‐sensitive potassium (KATP) channels, respectively. Multiple case reports of affected individuals have described the various clinical feature...
Saved in:
Published in | American journal of medical genetics. Part C, Seminars in medical genetics Vol. 181; no. 4; pp. 658 - 681 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken, USA
John Wiley & Sons, Inc
01.12.2019
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Cantú syndrome (CS), first described in 1982, is caused by pathogenic variants in ABCC9 and KCNJ8, which encode the regulatory and pore forming subunits of ATP‐sensitive potassium (KATP) channels, respectively. Multiple case reports of affected individuals have described the various clinical features of CS, but systematic studies are lacking. To define the effects of genetic variants on CS phenotypes and clinical outcomes, we have developed a standardized REDCap‐based registry for CS. We report phenotypic features and associated genotypes on 74 CS subjects, with confirmed ABCC9 variants in 72 of the individuals. Hypertrichosis and a characteristic facial appearance are present in all individuals. Polyhydramnios during fetal life, hyperflexibility, edema, patent ductus arteriosus (PDA), cardiomegaly, dilated aortic root, vascular tortuosity of cerebral arteries, and migraine headaches are common features, although even with this large group of subjects, there is incomplete penetrance of CS‐associated features, without clear correlation to genotype. |
---|---|
Bibliography: | Funding information American Heart Association, Grant/Award Number: 19POST34380407; Children's Discovery Institute, Grant/Award Number: CH‐MD‐II‐2015‐488; CIMED Pilot and Feasibility Program, Grant/Award Numbers: CIMED‐14‐03, CIMED‐17‐01; E‐Rare Joint Transnational Cantu Treat Program, Grant/Award Number: I‐2101‐B26; National Institutes of Health, Grant/Award Number: HL140024 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 AUTHOR CONTRIBUTIONS Clinical assessments were carried out by D.K.G., J.M.L., E.P.K., I.S., S.F.S., G.K.S., M.M.H. Genetic analyses were carried out by H.I.R., K.D., Gv.H. Research clinic activities were coordinated by D.K.G., H.I.R, C.Mc.C, K.S., M.S.R., N.V.A.M.K., J.M.L, G.K.S., M.M.H., C.G.N. and Gv.H. The registry was developed by D.K.G. and K.S., and data were maintained and analyzed by D.K.G., H.I.R., C.Mc.C., K.S., M.S.R., C.G.N. The article was written by D.K.G., H.I.R., C.Mc.C., C.G.N., and edited by other authors. |
ISSN: | 1552-4868 1552-4876 1552-4876 |
DOI: | 10.1002/ajmg.c.31753 |